Aimin M. Zang
No. 648, Dongfeng East Road
Baoding, 071000, China
Baoding, 071000, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 83 publications
Ensartinib in Resected ALK-Positive Non-Small-Cell Lung Cancer.
Journal: The New England journal of medicine
Published: July 08, 2026
Serplulimab Plus Chemotherapy, with or without HLX04, versus Chemotherapy as First-Line Treatment for Nonsquamous NSCLC: Final Survival Analysis of the Phase III ASTRUM-002 Study.
Journal: Cancer communications (London, England)
Published: January 08, 2026
Author Correction: Cancer biomarkers discovered using pan-cancer plasma proteomic profiling.
Journal: Nature biomedical engineering
Published: September 22, 2025
NALIRIFOX versus gemcitabine plus nab-paclitaxel in Chinese patients with advanced pancreatic adenocarcinoma: a randomized, open-label phase II trial.
Journal: Nature communications
Published: August 28, 2025
Chidamide impedes glycolysis but increases ferroptosis and cisplatin sensitivity of lung cancer cells through downregulating USP35.
Journal: BMC cancer
Published: June 04, 2025
Long-term follow-up results from the GLORY study: phase II study of gumarontinib in East Asian patients with MET exon 14 skipping mutated non-small cell lung cancer.
Journal: Translational lung cancer research
Published: June 03, 2025
Bioequivalence of two doxorubicin liposome formulations (LY01612 and Caelyx) using free and encapsulated doxorubicin concentrations in Chinese patients with advanced breast cancer.
Journal: International journal of clinical pharmacology and therapeutics
Published: June 02, 2025
First-line serplulimab plus chemotherapy with or without HLX04 versus chemotherapy in locally advanced or metastatic non-squamous non-small-cell lung cancer (ASTRUM-002): a randomised, double-blind, multicentre phase 3 trial.
Journal: The Lancet. Respiratory medicine
Published: April 24, 2025
Phase Ⅲ, multicenter, randomized comparative study of LY01005 and Zoladex® for patients with premenopausal breast cancer
Journal: Zhonghua zhong liu za zhi [Chinese journal of oncology]
Published: April 23, 2025
Epigenetic remodeling and apoptotic activation by Chidamide suppress small cell lung cancer in molecularly distinct subtypes.
Journal: Discover oncology
Published: April 21, 2025
Author Correction: First-line cadonilimab plus chemotherapy in HER2-negative advanced gastric or gastroesophageal junction adenocarcinoma: a randomized, double-blind, phase 3 trial.
Journal: Nature medicine
Published: March 27, 2025
Last Updated: 09/26/2026